Doppelherz® Active Vitamins for Vegetarians

Dosage form Application area Recommendations for use Contraindications Manufacturer
Read on
Certificate number:RU.77.99.11.003.Е.007720.06.14
Date of registration and renewal:25.06.2014
Dosage form: & nbspTablets weighing 1500 mg.
Classification "Composition" & nbsp BAD - vitamin and mineral complexes
Classification "Clinical" & nbsp BAD-sources of vitamin-mineral complexes Supplements of restorative action Supplements antioxidants Supplements containing calcium and phosphorus Supplements containing iron Supplements containing iodine Supplements containing zinc, copper, manganese Supplements that support the functions of the immune system Supplements that support the function of the cardiovascular system Supplements supporting the functions of the musculoskeletal system
Composition: & nbspComposition: calcium carbonate, MCC, iron fumarate, hypromellose, croscarmellose sodium, magnesium stearate, silicon dioxide, zinc oxide, cyanocobalamin, stearic acid, riboflavin, thiamine nitrate, titanium dioxide, vitamin D3, pyridoxine hydrochloride, potassium iodide.
Scope: & nbsp
For sale to the population through the pharmacy network and specialized shops, departments of the trade network as a biologically active food additive - an additional source of vitamins B1, B2, B6, B12, D3, calcium, iron, zinc, iodine.
Suggested Usage: & nbspAdults take 1 tablet 1 time per day with meals. Duration of admission is 1-2 months. After a break of 1 month, a second appointment is possible.
Contraindications:Individual intolerance to food components, pregnant and lactating women.
Special instructions:Before use, it is recommended to consult a doctor. Persons with thyroid disease should consult an endocrinologist.
Shelf life:3 years.
Storage conditions:Store in a dry and inaccessible place for children at a temperature not exceeding + 25 ° C.
Research protocols:
Expert conclusion of the FBUC of the Federal Target Program and the Federal Service for Consumer Rights Protection No. 10-2FTS / 2527 of 04.06.2014.
Recipient:Kvayser Pharma, Open CompanyKvayser Pharma, Open Company Russian Federation
Information update date: & nbsp20.04.2016
Instructions
Up